Delivery 10 days in advance! Qianren GMP Cleanroom Project Recognized Again by Jinqi
Founded in 2012, Biointron is a National High-Tech Enterprise and National Specialized, Refined, Unique and Innovative "Little Giant" Enterprise, focusing on CRO services for antibody expression, antibody discovery and optimization.
Biointron has built technological advantages in its antibody expression services at genetic, cellular and process levels, realizing standardization, automation and informatization. Its service quality has been recognized by multinational pharmaceutical companies. The company has served nearly 3,000 pharmaceutical clients from more than 20 countries and regions at home and abroad.
Leveraging its outstanding antibody expression capacity, Biointron empowers its antibody discovery and optimization business and delivers one-stop antibody discovery services. The service scope covers alpaca nanobody development, AbDrop single B-cell antibody development, antibody humanization, antibody affinity maturation, high-throughput ADC antibody conjugation, high-throughput fully human antibody development, cell line licensing, and antibody druggability analysis.
Back To List